Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13258)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2018 (publication date) through Dec 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Aggeletopoulou I, Assimakopoulos SF, Konstantakis C, Triantos C. Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease. World J Gastroenterol 2018; 24(36): 4093-4103 [PMID: 30271076 DOI: 10.3748/wjg.v24.i36.4093] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Aggeletopoulou I, Assimakopoulos SF, Konstantakis C, Triantos C. Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease. World J Gastroenterol 2018; 24(36): 4093-4103 [PMID: 30271076 DOI: 10.3748/wjg.v24.i36.4093] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i36/4093.htm |
| Number | Citing Articles |
| 1 |
Aleksandra Sokic-Milutinovic, Tomica Milosavljevic. Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy. Digestive Diseases 2024; 42(4): 325 doi: 10.1159/000535647
|
| 2 |
Michelle L. M. Mulder, Tamara W. van Hal, Mark H. Wenink, Hans J. P. M. Koenen, Frank H. J. van den Hoogen, Elke M. G. J. de Jong, Juul M. P. A. van den Reek, Johanna E. Vriezekolk. Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review. Arthritis Research & Therapy 2021; 23(1) doi: 10.1186/s13075-021-02545-4
|
| 3 |
Wasim Haidari, Sarah Al-Naqshabandi, Christine S Ahn, Richard S Bloomfeld, Steven R Feldman. Asymptomatic Crohn’s disease identified in a patient being treated with secukinumab: A case report. SAGE Open Medical Case Reports 2019; 7 doi: 10.1177/2050313X19893580
|
| 4 |
Valerie Planat-Benard, Audrey Varin, Louis Casteilla. MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.626755
|
| 5 |
Tim Niehues, Gerd Horneff, Catharina Schütz, Prasad Thomas Oommen. Pädiatrische Rheumatologie. Springer Reference Medizin 2022; : 239 doi: 10.1007/978-3-662-60410-6_18
|
| 6 |
М. V. Osikov, Е. V. Simonyan, A. E. Bakeeva, O. I. Ogneva. Immunotropic effects of Curcuma longa extract as a component of original rectal suppositories in the dynamics of experimental Сrohn’s disease. Medical Immunology (Russia) 2020; 22(3): 483 doi: 10.15789/1563-0625-IEO-1875
|
| 7 |
Alexander Deck, Savannah Lane, Amber Liles, Nerissa T. Viola. Nuclear Imaging Strategies to Evaluate Cytokine Production in Autoimmune, Inflammatory, and Neoplastic Diseases: A Review of Current Preclinical Research. Journal of Nuclear Medicine 2025; : jnumed.125.270425 doi: 10.2967/jnumed.125.270425
|
| 8 |
Yasmin Zurba, Beatriz Gros, Mohammad Shehab. Exploring the Pipeline of Novel Therapies for Inflammatory Bowel Disease; State of the Art Review. Biomedicines 2023; 11(3): 747 doi: 10.3390/biomedicines11030747
|
| 9 |
J. Posner, P. Barrington, T. Brier, A. Datta-Mannan. Concepts and Principles of Pharmacology. Handbook of Experimental Pharmacology 2019; 260: 81 doi: 10.1007/164_2019_323
|
| 10 |
Brian Bressler, Jennifer Jones, Tracy S. H. In, Tommy Lan, Cristian Iconaru, John K. Marshall. Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease. Advances in Therapy 2023; 40(10): 4421 doi: 10.1007/s12325-023-02611-0
|
| 11 |
Hicheme Hadji, Kawthar Bouchemal. Advances in the treatment of inflammatory bowel disease: Focus on polysaccharide nanoparticulate drug delivery systems. Advanced Drug Delivery Reviews 2022; 181: 114101 doi: 10.1016/j.addr.2021.114101
|
| 12 |
Lara Chaaban, Tarek Harb, Gary Gerstenblith, Thorsten M. Leucker, Joanna Melia. Advanced biologic therapies and cardiovascular events in patients with inflammatory bowel disease. American Journal of Preventive Cardiology 2025; 22: 100991 doi: 10.1016/j.ajpc.2025.100991
|
| 13 |
Anna-Lena Unterweger, Morten Ø Jensen, Fabrizio Giordanetto, Vishwanath Jogini, Alena Rüschher, Marietta Seuß, Paula Winkelmann, Leandra Koletzko, David E Shaw, Matthias Siebeck, Roswitha Gropp, Florian Beigel, Attila Aszodi. Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanised Mouse Model of Ulcerative Colitis. Journal of Crohn's and Colitis 2021; 15(11): 1943 doi: 10.1093/ecco-jcc/jjab078
|
| 14 |
Interleukin in Immune-Mediated Diseases: An Updated Review. Molecular Biotechnology 2025; 67(12): 4403 doi: 10.1007/s12033-024-01347-8
|
| 15 |
Ruby A. Parikh, Benjamin C. Chaon, Meghan K. Berkenstock. Ocular Complications of Checkpoint Inhibitors and Immunotherapeutic Agents: A Case Series. Ocular Immunology and Inflammation 2021; 29(7-8): 1585 doi: 10.1080/09273948.2020.1766082
|
| 16 |
Recapitulating the Stem Cell Niche Ex Vivo. Advances in Stem Cells and their Niches 2022; 6: 57 doi: 10.1016/bs.asn.2021.10.001
|
| 17 |
Lisza Niarisessa, Anisa Nova Puspitaningrum, Arief Rahman Afief, Dyah Aryani Perwitasari, Wirawan Adikusuma, Rocky Cheung, Abdi Wira Septama, Lalu Muhammad Irham. Identification of Biological Risk Genes and Candidate Drugs for Psoriasis Vulgaris by Utilizing the Genomic Information. Borneo Journal of Pharmacy 2023; 6(2): 110 doi: 10.33084/bjop.v6i2.4217
|
| 18 |
Yi Chen, Jiaqi Zhang, Junling Wu, Hanwen Zhang, Zhe Luan, Zhizhuang Zhao, Congyong Li, Yiming Zhao, Hu Zhang, Shufang Wang, Gang Sun. A bibliometric and visual analysis of the use of ustekinumab in Crohn’s disease using CiteSpace. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1322319
|
| 19 |
Amand F. Schmidt, Chris Finan, Maria Gordillo-Marañón, Folkert W. Asselbergs, Daniel F. Freitag, Riyaz S. Patel, Benoît Tyl, Sandesh Chopade, Rupert Faraway, Magdalena Zwierzyna, Aroon D. Hingorani. Genetic drug target validation using Mendelian randomisation. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-16969-0
|
| 20 |
Juan He, Hong Guo, Min Zou. Research advances in nanomaterials with aromatic functional groups for the treatment of inflammatory bowel disease. Frontiers in Bioengineering and Biotechnology 2025; 13 doi: 10.3389/fbioe.2025.1614939
|
| 21 |
Breana Channer, Stephanie M. Matt, Emily A. Nickoloff-Bybel, Vasiliki Pappa, Yash Agarwal, Jason Wickman, Peter J. Gaskill. Dopamine, Immunity, and Disease. Pharmacological Reviews 2023; 75(1): 62 doi: 10.1124/pharmrev.122.000618
|
| 22 |
M. J. García, M. Pascual, C. Del Pozo, A. Díaz-González, B. Castro, L. Rasines, J. Crespo, M. Rivero. Impact of immune-mediated diseases in inflammatory bowel disease and implications in therapeutic approach. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-67710-2
|
| 23 |
Yinzhu Jin, Hemin Lee, Moa P. Lee, Joan E. Landon, Joseph F. Merola, Rishi J. Desai, Seoyoung C. Kim. Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis. Arthritis Care & Research 2022; 74(11): 1792 doi: 10.1002/acr.24630
|
| 24 |
Jingyun Xu, Lijia Wu, Pengcheng Yu, Yichun Sun, Yixin Lu. Effect of T. spiralis Serine protease inhibitors on TNBS-induced experimental colitis mediated by Macrophages. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60155-7
|
| 25 |
Mark Robbins, Karen Doucette. Infectious Complications in Biologic and Targeted Therapies. 2022; : 431 doi: 10.1007/978-3-031-11363-5_23
|
| 26 |
Diego Casas-Deza, Luis Javier Lamuela-Calvo, Fernando Gomollón, José Miguel Arbonés-Mainar, Berta Caballol, Javier P Gisbert, Montserrat Rivero, Eugenia Sánchez-Rodríguez, Lara Arias García, Ana Gutiérrez Casbas, Olga Merino, Lucía Márquez, Viviana Laredo, María Dolores Martín-Arranz, Pilar López Serrano, Sabino Riestra Menéndez, Carlos González-Muñoza, Luisa de Castro Parga, Marta Calvo Moya, Esteban Fuentes-Valenzuela, Maria Esteve, Marisa Iborra, Miguel Dura Gil, Manuel Barreiro-De Acosta, Rufo Humberto Lorente-Poyatos, Noemí Manceñido, Margalida Calafat, Iago Rodríguez-Lago, Jordi Guardiola Capo, Maria Antonia Payeras, Víctor Jair Morales Alvarado, Carlos Tardillo, Luis Bujanda, José Fernando Muñoz-Nuñez, Yolanda Ber Nieto, Fernando Bermejo, Pedro Almela, Mercè Navarro-Llavat, Pilar Martínez Montiel, Cristina Rodríguez Gutiérrez, Manuel Van Domselaar, Eva Sesé, Teresa Martínez Pérez, Elena Ricart, María Chaparro, María José García, Antonio López-Sanromán, Beatriz Sicilia, Beatriz Orts, Alicia López-García, Eduardo Martín-Arranz, José Lázaro Pérez-Calle, Ruth de Francisco, Esther García-Planella, Eugeni Domènech, y Santiago García-López. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn’s Disease: Real World Evidence From the ENEIDA Registry. Journal of Crohn's and Colitis 2023; 17(1): 83 doi: 10.1093/ecco-jcc/jjac108
|
| 27 |
Ralley E. Prentice, Aysha Al‐Ani, Britt Christensen. Managing COVID‐19 in patients with inflammatory bowel disease: navigating unprecedented challenges. Internal Medicine Journal 2021; 51(2): 284 doi: 10.1111/imj.15190
|
| 28 |
Aleksandra Korta, Julia Kula, Krzysztof Gomułka. The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease. International Journal of Molecular Sciences 2023; 24(12): 10172 doi: 10.3390/ijms241210172
|
| 29 |
Warren C Carll, Mohamed Y Rady, Marcela A Salomao, Bhavesh Patel, Vijay P Singh, Ayan Sen. Cytomegalovirus haemorrhagic enterocolitis associated with severe infection with COVID-19. BMJ Open Gastroenterology 2021; 8(1): e000556 doi: 10.1136/bmjgast-2020-000556
|
| 30 |
Yingnan Han, Clarence Wang, Katherine Klinger, Deepak K. Rajpal, Cheng Zhu, Jishnu Das. An integrative network-based approach for drug target indication expansion. PLOS ONE 2021; 16(7): e0253614 doi: 10.1371/journal.pone.0253614
|
| 31 |
Vera Fominykh, Alexey A. Shadrin, Piotr Jaholkowski, Julian Fuhrer, Nadine Parker, Erik D. Wiström, Oleksandr Frei, Olav B. Smeland, Helga Sanner, Srdjan Djurovic, Ole A. Andreassen. Mapping the genetic landscape of immune-mediated disorders: potential implications for classification and therapeutic strategies. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1543781
|
| 32 |
Isha T. Shah, Manya D. Desai, Namrata B. Parmar, Priyajeet S. Parekh, Mayur R. Yadav, Palak A. Shah, Mehul R. Chorawala. Immunotherapy for ulcerative colitis: targeting innate and adaptive immune responses for better clinical outcomes. The Egyptian Journal of Internal Medicine 2025; 37(1) doi: 10.1186/s43162-025-00461-6
|
| 33 |
Karina Polak, Beata Bergler-Czop, Michał Szczepanek, Kamila Wojciechowska, Aleksandra Frątczak, Norbert Kiss. Psoriasis and Gut Microbiome—Current State of Art. International Journal of Molecular Sciences 2021; 22(9): 4529 doi: 10.3390/ijms22094529
|
| 34 |
Benjamin Misselwitz, Pascal Juillerat, Michael Christian Sulz, Britta Siegmund, Stephan Brand. Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More. Digestion 2020; 101(Suppl. 1): 69 doi: 10.1159/000507782
|
| 35 |
Mladen Merćep. Drug Interactions in Gastroenterology. Clinical Gastroenterology 2024; : 135 doi: 10.1007/978-3-031-69800-2_9
|
| 36 |
Steven A Svoboda, Patrick S Rush, Kevin G Sharghi, Peter L Rady, Stephen K Tyring, Joshua D Eikenberg. A case report of disseminated verrucosis secondary to ustekinumab in a patient with Crohn’s disease. SAGE Open Medical Case Reports 2021; 9 doi: 10.1177/2050313X211003056
|
| 37 |
Aniek Plug, Liana Barenbrug, Bart G.J. Moerings, Elke M.G. de Jong, Renate G. van der Molen. Understanding the role of immune-mediated inflammatory disease related cytokines interleukin 17 and 23 in pregnancy: A systematic review. Journal of Translational Autoimmunity 2025; 10: 100279 doi: 10.1016/j.jtauto.2025.100279
|
| 38 |
Run Liu, Zhidian Wu, Hang Yu. Effect of different treatments on macrophage differentiation in chronic obstructive pulmonary disease and repeated pulmonary infection. Saudi Journal of Biological Sciences 2020; 27(8): 2076 doi: 10.1016/j.sjbs.2020.05.038
|
| 39 |
Rhonda M. Brand, Beth Dudley, Eve Karloski, Ashley Zyhowski, Rebecca Raphael, Danielle Pitlor, E. Jeffrey Metter, Reet Pai, Kenneth Lee, Randall E. Brand, Shikhar Uttam. Immune microenvironment profiling of normal appearing colorectal mucosa biopsied over repeat patient visits reproducibly separates lynch syndrome patients based on their history of colon cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1174831
|
| 40 |
Ahmed Aljabri, Ghareb M. Soliman, Yasmin N. Ramadan, Mohammed A. Medhat, Helal F. Hetta. Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01558-6
|
| 41 |
Serena Artone, Alessia Ciafarone, Francesca Rosaria Augello, Francesca Lombardi, Maria Grazia Cifone, Paola Palumbo, Benedetta Cinque, Giovanni Latella. Evaluation of the Antifibrotic Effects of Drugs Commonly Used in Inflammatory Intestinal Diseases on In Vitro Intestinal Cellular Models. International Journal of Molecular Sciences 2024; 25(16): 8862 doi: 10.3390/ijms25168862
|
| 42 |
L Debels, M Reynders, B Cauwelier, B Willandt, D Selleslag, C Snauwaert. Parvovirus B19-triggered hemophagocytic lymphohistiocytosis in a patient with Crohn’s disease. Acta Gastro Enterologica Belgica 2022; 85(3): 522 doi: 10.51821/85.3.9108
|
| 43 |
Rocío Rivera Rodríguez, Jeremy James Johnson. Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease. Pharmacology & Therapeutics 2023; 248: 108456 doi: 10.1016/j.pharmthera.2023.108456
|
| 44 |
Nabeel Khan, Ramaswamy Sundararajan, Dhruvan Patel, Manthankumar Patel, Janak Bahirwani, Nadim Mahmud. Comparative Risk of Serious Infections Associated With Treatment of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2025; doi: 10.1093/ibd/izaf218
|
| 45 |
Tim Niehues, Gerd Horneff, Catharina Schütz, Prasad Thomas Oommen. Pädiatrische Rheumatologie. Springer Reference Medizin 2021; : 1 doi: 10.1007/978-3-662-60411-3_18-1
|
| 46 |
Duaa Ahmed Elhag, Manoj Kumar, Marwa Saadaoui, Anthony K. Akobeng, Fatma Al-Mudahka, Mamoun Elawad, Souhaila Al Khodor. Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response. International Journal of Molecular Sciences 2022; 23(13): 6966 doi: 10.3390/ijms23136966
|
| 47 |
Tina Nie. Treating paediatric Crohn’s disease is challenging but new treatments hold promise. Drugs & Therapy Perspectives 2024; 40(3): 121 doi: 10.1007/s40267-024-01056-x
|
| 48 |
Mirjana Turkalj. Drug Interactions in Gastroenterology. Clinical Gastroenterology 2024; : 419 doi: 10.1007/978-3-031-69800-2_25
|